April 2014 FDA Recall Drug by Bacai Inc. Dba Ky Duyen House
D-1534-2014 - Marketed Without an Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Bacai Inc. Dba Ky Duyen House on April 30, 2014 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed in Worldwide via internet sales and the recall is currently terminated.

Recall Number: D-1534-2014

Reason for Recall
Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.
Initiated
04-30-2014
Reported
08-20-2014
Quantity
14,040 softgel capsules

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Bacai Inc. Dba Ky Duyen House
Worldwide via internet sales
Lite Fit USA, For Men & Women, Extreme Fat Burner, Suppresses Appetite, Boosts Metabolism, Limits Fat Absorption, Increases Energy, Prevents lipid formation by limiting fat absorption 30 pills /Bottle, Distributed by: Bacai, INC. www.litefitusa.com

Batch or Lot Expiration Information

Lot# 13165; Exp. 05/17